Please read Dr. Hudson’s article in the Journal of Medical Internet Research titled, “Demographic and Psychosocial Characteristics Associated With Use of a Prostate Cancer Survivorship Website: Implications From a Multisite Randomized Controlled Trial.“
Prostate cancer (PC) is the second most common cancer diagnosed in men in the United States, with about 1 in 9 men diagnosed during their lifetime. The American Cancer Society estimates that, in 2021, there will be 248,530 new cases of PC in the United States. The 5-year relative survival rate for localized PC is near 100%. Consequently, the population of PC survivors is growing, exhibiting specific disease and treatment-related symptomatology in both the physical (eg, urinary, bowel, or sexual dysfunction) and psychosocial (eg, high rates of distress, anxiety, reduced quality of life, depression, adjustment difficulties, fear of cancer recurrence) domains. Further, studies have shown there is a significant interpersonal impact of PC on patients’ relationships with their spouses and loved ones, as they struggle with intimacy, sexual confidence, sense of masculinity, familial cancer risk, and communicating about their diagnosis, treatment, and symptoms with friends. To read the full article.
Demographic and Psychosocial Characteristics Associated With Use of a Prostate Cancer Survivorship Website: Implications From a Multisite Randomized Controlled Trial. Marziliano A, Diefenbach MA, Hudson SV, Tagai EK, Handorf EA, Bator A, Miller SM. J Med Internet Res. 2022 Mar 21;24(3):e27890. PMID: 35311678 PMCID: PMC8981019 DOI: 2196/27890 Clinical Trial.